Notifying Person Name: Euroclone SpA Position: Closely associated person (X) Legal Person (1): Associated Person Name: Aiolfi, Franco Position: Member of the Board Issuer name: Biohit Plc LEI: 74370089ATTSNBXJVT29 Notification Type: INITIAL NOTIFICATION Notification reference: 74370089ATTSNBXJVT29_20200131170019_3 ____________________________________________ Transaction date: 2020-01-28 Transaction place not applicable Instrument: SHARE ISIN: FI0009005482 Nature of transaction: OTHER Description of transaction: Transfer of shares from Franco Aiolfi’s previously managed and controlled Euroclone SpA to Franco Aiolfi’s managed and controlled BioAir SpA Transaction details (1): Volume: 92 807 Price: EUR Aggregated Information (1): Volume: 92 807 Average Price: EUR Additional information: CEO Semi Korpela, Biohit Oyj tel. +358 9 773 861 investor.relations@biohit.fi www.biohithealthcare.com Biohit Oyj in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission ‘Innovating for Health’ means that we provide innovative products and services to promote research and early diagnostics. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s B series shares (BIOBV) are quoted on NASDAQ OMX Helsinki under Small cap/Healthcare. www.biohithealthcare.com